Article 1 to 1 out of 1 concerning Jenapharm GmbH & Co. KG
Schering sells Jenapharm's therapeutics business to Dermapharm AG(13 Aug 2004) Schering AG, Germany (FSE: SCH, NYSE: SHR) announced today that its German subsidiary Jenapharm GmbH & Co. KG, Jena, has agreed the sale of its therapeutics business to mibe Vertriebsgesellschaft mbH (i.G.), Jena, a subsidiary of Dermapharm AG, ...
Top